For the Inventor, By the Inventor

Enter assignee name

Boehringer Mannheim Italia

Calculating rank

USPTO Granted Patents = 27

CIPO Patents = 1

Forward Citations = 142

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Silvano Spinelli (16 out of 40 patents)

Ernesto Menta (9 out of 36 patents)

Sergio Tognella (8 out of 28 patents)

4. Licia Gallico (6 out of 7 patents)

5. Carmelo A Gandolfi (6 out of 33 patents)

6. Giorgio Long (5 out of 5 patents)

7. A Paul Krapcho (4 out of 6 patents)

8. Marco Frigerio (3 out of 34 patents)

9. Valeria Livi (3 out of 9 patents)

10. Ambrogio Oliva (3 out of 13 patents)

11. Roberto Di Domenico (3 out of 10 patents)

12. Antonella Rozzi (3 out of 3 patents)

13. Carlo Bugatti (2 out of 4 patents)

14. Carlo Riva (2 out of 38 patents)

15. Mariella Valsecchi (2 out of 4 patents)

Core Competencies:

Platinum Complexes

Antitumor Activity

Immunoassay

Chemoprotective Agents

Heterocyclic Amines

Asthma Therapy

Gem-Diphosphonic Acids

Thiazole Derivatives

Polysubstituted Compounds

Dihydropyridines

Anti-Inflammatory

Antineoplastic Agents

27 patents: Sort by Forward Citations

1. 5744497 - Trinuclear cationic platinum complexes having antitumor activity and (1998-04-28),

2. 5731162 - Method and analytical device for simultaneous immunoassay (1998-03-24),

3. 5717099 - Method of synthesis for (1998-02-10),

4. 5618823 - Glutathione as chemoprotective agent (1997-04-08),

5. 5607930 - 1,4-disubstituted piperazines useful in the therapy of the asthma and of (1997-03-04),

6. 5604246 - 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H)-ones (1997-02-18),

7. 5596097 - Hetero-annulated indazoles (1997-01-21),

8. 5587382 - 6,9-bis[(2-aminoethyl) amino]benzo [g]isoquinoline-5,10- dione (1996-12-24),

9. 5543401 - UDPG as a rescue agent in cancer therapy after the administration of (1996-08-06),

10. 5519029 - 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H)-ones (1996-05-21),

11. 5506232 - 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its (1996-04-09),

12. 5494900 - UDPG as a rescue agent in cancer therapy after the administration of (1996-02-27),

13. 5464844 - [3H,7H]thiazole[3,4-a]pyridines having antiasthmatic and (1995-11-07),

14. 5453423 - Heterocyclic amines useful in the therapy of asthma and imflammation of (1995-09-26),

15. 5446187 - Aminoacyl derivatives of gem-diphosphonic acids, a process for the (1995-08-29),

Company Overview

Boehringer Mannheim Italia, part of the global Boehringer Ingelheim group, specializes in the development and manufacturing of innovative healthcare solutions. The company focuses on diagnostics and therapeutic areas, particularly in human and veterinary medicine. With a commitment to advancing medical science, it engages in research across various domains, including biopharmaceuticals and diagnostics, contributing to improved health outcomes in Italy and beyond.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

27 Patents

#67 in Milan

#348 in Italy

#24,046 in the World

Boehringer Mannheim Italia

Forward Citations = 142

42 inventors:

Silvano Spinelli (16 out of 40 patents)

Ernesto Menta (9 out of 36 patents)

Sergio Tognella (8 out of 28 patents)

4. Licia Gallico (6 out of 7 patents)

5. Carmelo A Gandolfi (6 out of 33 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Boehringer Mannheim Italia. Retrieved from https://idiyas.com/company/boehringer-mannheim-italia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…